Taking on the RAS Challenge October 8, 2026, by Linda Wang

https://www.cancer.gov/news-events/cancer-currents-blog/2026/taking-on-ras-challenge?cid=eb_govdel For decades, RAS proteins were considered nearly impossible to target with drugs. NCI-supported basic research and the RAS Initiative helped lay the groundwork for new RAS inhibitors that are now benefiting patients and advancing through clinical trials.